This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Insilico Medicine reports positive Phase IIa results for ISM001-055 for the treatment of idiopathic pulmonary fibrosis (IPF) designed using generative AI

24 SEP, 2024

Subscribe to our News & Updates